EVOK News and Press, Evoke Pharma Inc. From 01/21/20

CSS Industries (NYSE: CSS ) +99%  on being acquired by IG Design Group plc. More news on: CSS Industries, Inc., Novavax, Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...

The FDA has accepted for review Evoke Pharma's (NASDAQ: EVOK ) resubmitted marketing application for Gimoti (metoclopramide) nasal spray for the relief of symptoms in adult women with acute and recurrent diabetic gastroparesis. More news on: Evoke Pharma, Inc., Healthcare stocks news, St...

SOLANA BEACH, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI) disorders and diseases, today announced that the U.S. Food and Drug Administration (FDA) has accep...

SOLANA BEACH, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has resubmitted its 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug ...

SOLANA BEACH, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that on November 29, 2019, it received notification from the Listing Qualifications Departm...

SOLANA BEACH, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that on November 12, 2019, it received notification from the Listing Qualifications Departm...

Evoke Pharma (NASDAQ: EVOK ): Q3 GAAP EPS of -$0.07 beats by $0.02 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SOLANA BEACH, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the third quarter ended September 30, 2019. “We made si...

SOLANA BEACH, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has completed manufacturing commercial scale batches of its product candidate Gimo...

Evoke Pharma (NASDAQ: EVOK ): Q2 GAAP EPS of -$0.09 beats by $0.03 . Cash and equivalents of $7.4M Press Release More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, ,